drugset / Trial / NCT03080142

TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery

NCT03080142 ↗

Phase 4 Completed 86 enrolled University of California, Davis
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective randomized study designed to compare the pain control from a single shot of liposomal bupivacaine (Exparel) against transversus abominus plane (TAP) catheters with ropivicaine bolus in patients undergoing elective colorectal surgery.

Timeline

Start
2017-03-01
Primary completion
2019-05-29
Completion
2019-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 60 ml Other
Comparator Ropivacaine Other / unclassified 0.2 % Other

Indications

No indication recorded.